Search

Lindsay E Hinck

from Santa Cruz, CA
Age ~63
Get Report
Also known as:
Etal Lindsay Hinck, Lindsay E Rorty
Phone and address:
831 California St, Santa Cruz, CA 95060
(831) 420-0986
Related to:
Amelie O RortyJay Rorty, 63Ruby Rorty
Connected to:
Brian L Hinck, 50Carolina Hinck, 34Claus F Hinck, 76Jim Hinck, 74Jordan N Hinck, 36Joshua Hinck, 43Lisa M Hinck, 59Matthew L Hinck, 55Sarah E Hinck, 45Walter D Hinck, 65

Lindsay Hinck Phones & Addresses

  • 831 California St, Santa Cruz, CA 95060 (831) 420-0986
  • San Francisco, CA
  • Redwood City, CA
  • Davis, CA
  • Magdalena, NM
  • Menlo Park, CA
  • Palo Alto, CA
  • 831 California St, Santa Cruz, CA 95060

Work

Company: Uc santa cruz Position: Professor

Education

Degree: Doctor of Philosophy (Ph.D.) School / High School: Stanford University 1989 to 1994 Specialities: Cancer Biology

Skills

Molecular Biology • Cell Biology • Western Blotting • Pcr • Molecular Cloning • Biochemistry • Protein Expression • Science • Genetics • Teaching • Grant Writing • Protein Purification

Industries

Higher Education

Resumes

Resumes

Lindsay Hinck Photo 1

Professor

View page
Location:
831 California St, Santa Cruz, CA 95060
Industry:
Higher Education
Work:
UC Santa Cruz
Professor
Education:
Stanford University 1989 - 1994
Doctor of Philosophy (Ph.D.), Cancer Biology
Skills:
Molecular Biology
Cell Biology
Western Blotting
Pcr
Molecular Cloning
Biochemistry
Protein Expression
Science
Genetics
Teaching
Grant Writing
Protein Purification

Business Records

Name / Title
Company / Classification
Phones & Addresses
Lindsay Hinck
Associate Professor Biology Department
University of California, Santa Cruz
University
1154 High St, Santa Cruz, CA 95064
1156 High St, Santa Cruz, CA 95064
(831) 459-4567, (831) 459-0111, (831) 459-5006

Publications

Us Patents

Netrin Receptors

View page
US Patent:
7041806, May 9, 2006
Filed:
Sep 27, 2002
Appl. No.:
10/256702
Inventors:
Mark Tessier-Lavigne - San Francisco CA, US
E. David Leonardo - San Francisco CA, US
Lindsay Hinck - San Francisco CA, US
Masayuki Masu - San Francisco CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
C07K 16/00
C12P 21/08
A61K 39/395
A61K 39/40
G01N 33/53
US Classification:
5303879, 5303871, 5303881, 53038822, 5303891, 5303913, 4241391, 4241411, 4241431, 4241781, 435 71
Abstract:
The invention provides methods and compositions relating to vertebrate UNC-5 proteins which function as receptor proteins for netrins, a family of cell guidance proteins. The proteins may be produced recombinantly from transformed host cells from the disclosed vertebrate UNC-5 encoding nucleic acid or purified from human cells. The invention provides specific hybridization probes and primers capable of specifically hybridizing with the disclosed vertebrate unc-5 gene, vertebrate UNC-5-specific binding agents such as specific antibodies, and methods of making and using the subject compositions in diagnosis, therapy and in the biopharmaceutical industry.

Netrin Receptors

View page
US Patent:
7919588, Apr 5, 2011
Filed:
May 1, 2008
Appl. No.:
12/151062
Inventors:
Marc Tessier-Lavigne - San Francisco CA, US
E. David Leonardo - San Francisco CA, US
Lindsay Hinck - San Francisco CA, US
Masayuki Masu - San Francisco CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
G01N 33/53
C07K 14/435
US Classification:
530350, 435 691, 4353201, 435325, 435 71, 514 11
Abstract:
The invention provides methods and compositions relating to vertebrate UNC-5 proteins which function as receptor proteins for netrins, a family of cell guidance proteins. The proteins may be produced recombinantly from transformed host cells from the disclosed vertebrate UNC-5 encoding nucleic acid or purified from human cells. The invention provides specific hybridization probes and primers capable of specifically hybridizing with the disclosed vertebrate unc-5 gene, vertebrate UNC-5-specific binding agents such as specific antibodies, and methods of making and using the subject compositions in diagnosis, therapy and in the biopharmaceutical industry.

Netrin Receptors

View page
US Patent:
20030040046, Feb 27, 2003
Filed:
Aug 20, 2001
Appl. No.:
09/933261
Inventors:
Marc Tessier-Lavigne - San Francisco CA, US
E. Leonardo - San Francisco CA, US
Lindsay Hinck - San Francisco CA, US
Masayuki Masu - San Francisco CA, US
International Classification:
C07K014/705
G01N033/53
C07H021/04
C12P021/02
C12N005/06
US Classification:
435/069100, 435/007100, 435/320100, 435/325000, 530/350000, 536/023500
Abstract:
The invention provides methods and compositions relating to vertebrate UNC-5 proteins which function as receptor proteins for netrins, a family of cell guidance proteins. The proteins may be produced recombinantly from transformed host cells from the disclosed vertebrate UNC-5 encoding nucleic acid or purified from human cells. The invention provides specific hybridization probes and primers capable of specifically hybridizing with the disclosed vertebrate unc-5 gene, vertebrate UNC-5-specific binding agents such as specific antibodies, and methods of making and using the subject compositions in diagnosis, therapy and in the biopharmaceutical industry.

Netrin Receptors

View page
US Patent:
20060147988, Jul 6, 2006
Filed:
Mar 7, 2006
Appl. No.:
11/370424
Inventors:
Marc Tessier-Lavigne - San Francisco CA, US
E. Leonardo - San Francisco CA, US
Lindsay Hinck - San Francisco CA, US
Masayuki Masu - San Francisco CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
C12Q 1/68
C07H 21/04
C12P 21/06
C07K 14/705
US Classification:
435006000, 530350000, 435069100, 435320100, 435325000, 536023500
Abstract:
The invention provides methods and compositions relating to vertebrate UNC-5 proteins which function as receptor proteins for netrins, a family of cell guidance proteins. The proteins may be produced recombinantly from transformed host cells from the disclosed vertebrate UNC-5 encoding nucleic acid or purified from human cells. The invention provides specific hybridization probes and primers capable of specifically hybridizing with the disclosed vertebrate unc-5 gene, vertebrate UNC-5-specific binding agents such as specific antibodies, and methods of making and using the subject compositions in diagnosis, therapy and in the biopharmaceutical industry.

Netrin Receptors

View page
US Patent:
62775855, Aug 21, 2001
Filed:
May 7, 1999
Appl. No.:
9/306902
Inventors:
Mark Tessier-Lavigne - San Francisco CA
E. David Leonardo - San Francisco CA
Lindsay Hinck - San Francisco CA
Masayuki Masu - San Francisco CA
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
G01N 3353
C07K 14435
US Classification:
435 71
Abstract:
The invention provides methods and compositions relating to vertebrate UNC-5 proteins which function as receptor proteins for netrins, a family of cell guidance proteins. The proteins may be produced recombinantly from transformed host cells from the disclosed vertebrate UNC-5 encoding nucleic acid or purified from human cells. The invention provides specific hybridization probes and primers capable of specifically hybridizing with the disclosed vertebrate unc-5 gene, vertebrate UNC-5-specific binding agents such as specific antibodies, and methods of making and using the subject compositions in diagnosis, therapy and in the biopharmaceutical industry.

Neurological Drug Screens

View page
US Patent:
57472629, May 5, 1998
Filed:
Oct 16, 1995
Appl. No.:
8/551874
Inventors:
Lindsay Hinck - San Francisco CA
Kasuko Masu - San Francisco CA
Masayuki Masu - San Francisco CA
David Leonardo - SF CA
Marc Tessier Lavigne - San Mateo CA
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
G01N 3353
US Classification:
435 71
Abstract:
Compositions for identifying lead compounds for pharmacological agents useful in the diagnosis or treatment of neurological disease or injury include mixtures comprising an isolated netrin and an isolated natural netrin receptor such as "Deleted in Colorectal Carcinoma" (DCC) and neogenin. The general methods involve incubating a mixture of an isolated mammalian netrin, an isolated natural mammalian netrin receptor, and a candidate pharmacological agent, and determining if the presence of the agent modulates the binding of the netrin to the receptor.

Netrin Receptor

View page
US Patent:
59392711, Aug 17, 1999
Filed:
Feb 19, 1997
Appl. No.:
8/808982
Inventors:
Mark Tessier-Lavigne - San Francisco CA
E. David Leonardo - San Francisco CA
Lindsay Hinck - San Francisco CA
Masayuki Masu - San Francisco CA
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
G01N 3353
C12N 1512
US Classification:
435 71
Abstract:
The invention provides methods and compositions relating to vertebrate UNC-5 proteins which function as receptor proteins for netrins, a family of cell guidance proteins. The proteins may be produced recombinantly from transformed host cells from the disclosed vertebrate UNC-5 encoding nucleic acid or purified from human cells. The invention provides specific hybridization probes and primers capable of specifically hybridizing with the disclosed vertebrate unc-5 gene, vertebrate UNC-5-specific binding agents such as specific antibodies, and methods of making and using the subject compositions in diagnosis, therapy and in the biopharmaceuticai industry.

Neurological Drug Screens

View page
US Patent:
60873264, Jul 11, 2000
Filed:
Jan 15, 1998
Appl. No.:
9/007604
Inventors:
Lindsay Hinck - San Francisco CA
Kasuko Masu - San Francisco CA
Masayuki Masu - San Francisco CA
David Leonardo - San Francisco CA
Marc Tessier-Lavigne - San Mateo CA
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 3802
A61K 3817
C07K 200
C07K 14435
US Classification:
514 2
Abstract:
Compositions for identifying lead compounds for pharmacological agents useful in the diagnosis or treatment of neurological disease or injury include mixtures comprising an isolated netrin and an isolated natural netrin receptor such as "Deleted in Colorectal Carcinoma" (DCC) and neogenin. The general methods involve incubating a mixture of an isolated mammalian netrin, an isolated natural mammalian netrin receptor, and a candidate pharmacological agent, and determining if the presence of the agent modulates the binding of the netrin to the receptor.
Control profile
Lindsay E Hinck from Santa Cruz, CA, age ~63 Get Report